Atlas Trials

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT01562301 · WITHDRAWN

Trial details

NCT number
NCT01562301
Sponsor
M.D. Anderson Cancer Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Chemotherapeutic Agent ToxicityLung Cancer
Start date
2014-06-01
Primary completion
2016-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.